Menon et al. (2009) |
Multi-modal and ultrasound for ovarian cancer; primary ovarian and tubal |
0.998 |
0.894 |
|
Primary invasive epithelial ovarian and tubal |
0.998 |
0.895 |
|
USS |
0.982 |
0.75 |
|
Citing van Nagell et al. (2007) |
0.987 |
0.763 |
Grim et al. (1979) |
Renal vascular hypertension screening test |
0.92 |
0.93 |
Weiss et al. (1985) |
HTLV-III (AIDS Agent) screening test |
0.986 |
0.973 |
Stoll et al. (1999) |
PTSD screening test |
0.975 |
0.77 |
Kulasingam et al. (2002) |
HPV testing thin-layer pap |
0.824 |
0.613 |
|
PCR |
0.788 |
0.882 |
|
Signal amplification |
0.726 |
0.908 |
Perkins et al. (2001) |
Peripheral neuropathy in Diabetes clinic |
Vibration (on off) |
0.99 |
0.53 |
|
|
Monofilament |
0.96 |
0.77 |
|
|
Superficial pain |
0.97 |
0.59 |
|
|
Vibration (timed) |
0.98 |
0.8 |
Deeks & Altman (2004) |
Obstructive airway disease and >40 pack-years smoking |
|
0.986 |
0.284 |
Doobay & Anand (2005) |
ABI and stroke |
CHD |
Newman et al. (1999) |
0.908 |
0.163 |
|
|
|
Abbott et al. (2000) |
0.944 |
0.167 |
|
|
Stroke |
Newman et al. (1999) |
0.908 |
0.17 |
|
|
|
Abbott et al. (2000) |
0.887 |
0.22 |
|
|
|
Tsai et al. (2001) |
0.972 |
0.092 |
Schiffman et al. (2000) |
HPV DNA testing for cervical cancer |
|
0.942 |
0.771 |
|
|
|
0.934 |
0.748 |
Mayrand et al. (2007) |
HPV for cervical cancer (conservative case) |
|
0.941 |
0.946 |
|
Pap for cervical cancer (conservative case) |
|
0.968 |
0.554 |
Sabroe et al. (1999) |
Autologous serum skin tests to screen for chronic idiopathic urticaria |
|
0.81 |
0.65 |
|
|
|
|
0.78 |
0.71 |
Maisel et al. (2001) |
B-natriuretic peptide for left ventricular dysfunction, 75 pg/mL BNP level |
|
0.98 |
0.86 |
Shumway-Cook et al. (2000) |
Probability of falls by timed up and go test |
|
0.87 |
0.87 |
Ferreira et al. (1992) |
Endomysial antibody screening for coeliac disease, four tests |
|
0.99 |
1 |
|
|
|
0.99 |
0.91 |
|
|
|
0.85 |
0.91 |
|
|
|
0.88 |
0.76 |
Watson et al. (2002) |
Various tests for Chlamydia |
PCR cervix |
1 |
0.965 |
|
|
LCR urine |
1 |
0.875 |
|
|
EIA urine |
1 |
0.188 |
|
|
EIA cervix |
1 |
0.52 |
|
|
EIA cervix |
0.99 |
0.8 |
|
|
DNA probe |
0.96 |
0.72 |
|
|
LET urine |
0.808 |
0.778 |
|
|
EIA urine |
0.99 |
0.75 |
|
|
EIA cervix |
1 |
0.844 |
|
|
PCR cervix |
1 |
1 |
|
|
LCR urine |
1 |
0.96 |
|
|
EIA urine |
1 |
0.37 |
|
|
EIA cervix |
1 |
0.783 |
|
|
PCR cervix |
1 |
1 |
|
|
PCR cervix |
1 |
0.85 |
|
|
PCR cervix |
1 |
0.953 |
|
|
PCR cervix |
0.986 |
1 |
|
|
PCR urine |
0.986 |
0.923 |
|
|
LCR cervix |
0.997 |
0.886 |
|
|
PCR, EIA cervix |
0.997 |
0.97 |
|
|
LET |
0.91 |
0.41 |
|
|
LCR and LET urine |
0.949 |
0.589 |
|
|
PCR urine |
0.997 |
0.82 |
|
|
PCR cervix |
0.998 |
0.82 |
|
|
PACE2 cervix |
1 |
0.795 |
|
|
PCR urine |
0.99 |
0.85 |
|
|
DFA cervix |
0.96 |
0.85 |
|
|
LCR urine |
1 |
0.882 |
|
|
EIA |
1 |
0.84 |
|
|
PCR cervix |
0.998 |
0.992 |
|
|
LCR, PCR |
1 |
0.93 |
|
|
LCR, PCR |
0.996 |
0.62 |
|
|
DFA cervix |
0.995 |
0.778 |
|
|
PCR cervix |
1 |
0.714 |
|
|
EIA cervix |
1 |
0.647 |
|
|
PCR urine |
0.993 |
0.895 |
Arbyn et al. (2008) |
Five cervical cancer screening tests (Table 3) |
VIA |
0.836 |
0.887 |
|
|
VILI |
0.832 |
0.957 |
|
|
VIAM |
0.855 |
0.826 |
|
|
Pap Smear |
0.985 |
0.651 |
|
|
HC2 |
0.93 |
0.721 |
Legro et al. (1998) |
Fasting glucose to insulin ratio to measure insulin sensitivity |
|
0.84 |
0.95 |
Schroeder et al. (1999) |
Noninvasive determination of endothelium-mediated vasodilation |
Coronary artery disease |
0.81 |
0.71 |
|
|
Angina pectoris |
0.571 |
0.824 |
Allison et al. (1996) |
Four tests for colorectal-screening |
Hemoccult II |
0.981 |
0.324 |
|
|
Hemoccult II Sensa |
0.875 |
0.712 |
|
|
Hemoselect |
0.952 |
0.672 |
|
|
Combined |
0.979 |
0.537 |
Ewer et al. (2011) |
Pulse oximetry screening for congenital heart defects |
Critical cases |
0.9912 |
0.75 |
|
|
All major cases |
0.9916 |
0.4906 |
Boppana et al. (2011) |
Saliva polymerase chain reaction assay for cytomegalovirus |
Liquid Saliva |
0.999 |
1 |
|
|
Dried Saliva |
0.999 |
0.974 |
Whitlock et al. (2008) |
Several colorectal cancer screening tests |
|
0.94 |
0.85 |
|
|
|
0.944 |
0.688 |
|
|
|
0.91 |
0.875 |
|
|
|
0.949 |
0.865 |
|
|
|
0.831 |
0.667 |
|
|
|
0.969 |
0.818 |
|
|
|
0.971 |
0.556 |
|
|
|
0.956 |
0.909 |
Cuzick et al. (2013) |
Six human papillomavirus tests |
BD HPV |
0.843 |
0.975 |
|
|
Roche Cobas |
0.845 |
0.975 |
|
|
Qiagen Hybrid |
0.854 |
0.975 |
|
|
Abbott real time |
0.872 |
0.95 |
|
|
Gen-probe |
0.902 |
0.975 |
|
|
NorChip |
0.952 |
0.714 |
Donovan et al. (2013) |
Various tests for gestational diabetes |
50-G OGCT |
0.86 |
0.85 |
|
|
50-G OGCT |
0.84 |
0.88 |
|
|
50-G OGCT |
0.83 |
0.85 |
|
|
50-G OGCT |
0.69 |
0.81 |
|
|
50-G OGCT |
0.89 |
0.7 |
|
|
50-G OGCT |
0.77 |
0.99 |
|
|
50-G OGCT |
0.66 |
0.88 |
|
|
50-G OGCT |
1 |
0.17 |
|
|
Fasting plasma glucose |
0.52 |
0.87 |
|
|
Fasting plasma glucose |
0.76 |
0.77 |
|
|
Fasting plasma glucose |
0.92 |
0.76 |
|
|
Fasting plasma glucose |
0.93 |
0.54 |
|
|
HbA 1c |
0.28 |
0.92 |
|
|
HbA 1c |
0.97 |
0.12 |
|
|
HbA 1c |
0.61 |
0.86 |
|
|
HbA 1c |
0.21 |
0.82 |
Ng et al. (2013) |
MRI and mammographic screening in survivors of Hodgkin Lymphoma |
Mammogram |
0.93 |
0.68 |
|
|
MRI |
0.94 |
0.67 |
|
|
Both |
0.9 |
0.94 |
Jafari et al. (2013) |
Various tests for syphilis (imperfect reference) |
|
|
|
|
|
Determine |
Serum |
0.9415 |
0.9004 |
|
|
|
Whole Blood |
0.9585 |
0.8632 |
|
|
SD Bioline |
Serum |
0.9585 |
0.8706 |
|
|
|
Whole Blood |
0.9795 |
0.845 |
|
|
Syphicheck |
Serum |
0.9914 |
0.7448 |
|
|
|
Whole Blood |
0.9958 |
0.7447 |
|
|
Visitect |
Serum |
0.9645 |
0.8513 |
|
|
|
Whole Blood |
0.9943 |
0.7426 |
Salami et al. (2013) |
Various tests for prostate cancer |
Optimized |
0.9 |
0.8 |
Kloten et al. (2013) |
Various tests for blood-based breast cancer screening |
RASSF1A UTIH5 |
0.73 |
0.54 |
|
|
RASSF1A DKK3 |
0.75 |
0.59 |
|
|
DKK3 ITIH5 |
0.94 |
0.4 |
|
|
RASSF1A DKK3 ITH5 |
0.72 |
0.67 |
Firnhaber et al. (2013) |
Cervical cancer screening methods in HIV positive women CIN 2+ |
Cytology (MD intern) |
0.681 |
0.755 |
|
|
HPV |
0.514 |
0.919 |
|
|
Cytology (RN intern) |
0.685 |
0.654 |
Teertstra et al. (2009) |
Breast tomosynthesis compared to mammography for detection of cancer |
Mammography |
0.883 |
0.963 |
|
|
Tomosynthesis |
0.867 |
0.963 |
Rafferty et al. (2013) |
Breast tomosynthesis compared to mammography for detection of cancer |
Mammography |
0.841 |
0.655 |
|
|
Mammography plus |
0.892 |
0.762 |
|
|
Tomosynthesis |
0.862 |
0.627 |
|
|
Mammography |
0.845 |
0.787 |
|
|
Mammography plus Tomosynthesis |
|
|
Catalona et al. (1991) |
Prostate-specific antigen in serum screening test |
Rectal examination |
0.44 |
0.86 |
|
|
Ultrasonography |
0.27 |
0.92 |
|
|
Serum PSA |
0.59 |
0.79 |